CHC LABS INC.
|
HUMAN IMMUNODEFICIENCY VIRUS TESTING (DIAGNOSIS) (86689,86701,86702,86703,87390,87391,87534,87535,87537,87538) |
|
|
003.1 |
Salmonella septicemia |
|
007.2 |
Coccidiosis |
|
007.4 |
Cryptosporidiosis |
|
007.8 |
Other specified protozoal intestinal diseases |
|
010.00-010.96 |
Primary tuberculous complex unspecified examination |
|
011.00-011.96 |
Tuberculosis of lung infiltrative confirmation unspecified |
|
012.00-012.86 |
Tuberculous pleurisy confirmation unspecified |
|
013.00-013.96 |
Tuberculous meningitis unspecified examination |
|
014.00-014.86 |
Tuberculous peritonitis unspecified examination |
|
015.00-015.96 |
Tuberculosis of vertebral column unspecified examination |
|
016.00-016.96 |
Tuberculosis of kidney unspecified examination |
|
017.00-017.96 |
Tuberculosis of skin and subcutaneous cellular tissue unspecified examination |
|
018.00-018.96 |
Acute miliary tuberculosis unspecified examination |
|
027.0 |
Listeriosis |
|
031.0-031.9 |
Pulmonary diseases due to other mycobacteria |
|
038.2 |
Pneumococcal septicemia |
|
038.43 |
Septicemia due to pseudomonas |
|
039.0-039.9 |
Cutaneous actinomycotic infection |
|
041.7 |
Pseudomonas infection in conditions classified elsewhere and of unspecified site |
|
042 |
Human immunodeficiency virus (HIV) disease |
|
046.3 |
Progressive multifocal leukoencephalopathy |
|
049.0-049.9 |
Non-arthropod-borne lymphocytic choriomeningitis |
|
052.0-052.8 |
Postvaricella encephalitis |
|
053.0-053.9 |
Herpes zoster with meningitis |
|
054.0-054.9 |
Eczema herpeticum |
|
055.0-055.8 |
Postmeasles encephalitis |
|
070.20-070.23 |
Viral hepatitis B with hepatic coma acute or unspecified without hepatitis delta |
|
070.30-070.33 |
Viral hepatitis B without hepatic coma acute or unspecified without hepatitis delta |
|
070.41 |
Acute or unspecified hepatitis C with hepatic coma |
|
070.42 |
Hepatitis delta without active hepatitis B disease with hepatic coma hepatitis delta with hepatitis B carrier state |
|
070.49 |
Other specified viral hepatitis with hepatic coma |
|
070.51 |
Acute or unspecified hepatitis C without hepatic coma |
|
070.52 |
Hepatitis delta without active hepatitis B disease or hepatic coma |
|
070.54 |
Chronic hepatitis C without hepatic coma |
|
070.59 |
Other specified viral hepatitis without hepatic coma |
|
070.6 |
Unspecified viral hepatitis with hepatic coma |
|
070.70 |
Unspecified viral hepatitis C without hepatic coma |
|
070.71 |
Unspecified viral hepatitis C with hepatic coma |
|
070.9 |
Unspecified viral hepatitis without hepatic coma |
|
078.0 |
Molluscum contagiosum |
|
078.10-078.19 |
Viral warts unspecified |
|
078.3 |
Cat-scratch disease |
|
078.5 |
Cytomegaloviral disease |
|
078.88 |
Other specified diseases due to chlamydiae |
|
079.50 |
Retrovirus unspecified |
|
079.51 |
Human T-cell lymphotrophic virus type I [HTLV-I] |
|
079.52 |
Human T-cell lymphotrophic virus type II {HTLV-II] |
|
079.53 |
Human immunodeficiency virus type 2 [HIV-2] |
|
079.59 |
Other specified retrovirus |
|
079.88 |
Other specified chlamydial infection |
|
079.98 |
Unspecified chlamydial infection |
|
085.0-085.9 |
Leishmaniasis visceral (KALA-AZAR) |
|
088.0 |
Bartonellosis |
|
090.0-090.9 |
Early congenital syphilis symptomatic |
|
091.0-091.9 |
Genital syphilis (Primary) |
|
092.0-092.9 |
Early syphilis latent serological relapse after treatment |
|
093.0-093.9 |
Aneurysm of aorta specified as syphilitic |
|
094.0-094.9 |
Tabes dorsalis |
|
095.0-095.9 |
Syphilitic episcleritis |
|
096 |
Late syphilis latent |
|
097.0-097.9 |
Late syphilis unspecified |
|
098.0-098.89 |
Gonococcal infection (acute) of lower genitourinary tract |
|
099.0 |
Chancroid |
|
099.1 |
Lymphogranuloma venereum |
|
099.2 |
Granuloma inguinale |
|
099.3 |
Reiter’s disease |
|
099.40-099.49 |
Other nongonococcal urethritis unspecified |
|
099.50-099.59 |
Other venereal diseases due to chlamydia trachomatis unspecified site |
|
099.8 |
Other specified venereal diseases |
|
099.9 |
Venereal disease unspecified |
|
110.1 |
Dermatophytosis of nail |
|
111.0 |
Pityriasis versicolor |
|
112.0-112.9 |
Candidiasis of mouth |
|
114.0-114.9 |
Primary coccidioidomycosis (pulmonary) |
|
115.00-115.99 |
Infection by histoplasma capsulatum without manifestation |
|
116.0-116.2 |
Blastomycosis |
|
117.3 |
Aspergillosis |
|
117.5 |
Cryptococcosis |
|
118 |
Opportunistic mycoses |
|
127.2 |
Strongyloidiasis |
|
130.0-130.9 |
Meningoencephalitis due to toxoplasmosis |
|
131.01 |
Trichomonal vulvovaginitis |
|
132.2 |
Phthirus pubis (pubic louse) |
|
133.0 |
Scabies |
|
136.2 |
Specific infections by free-living amebae |
|
136.3 |
Pneumocystosis |
|
136.8 |
Other specified infectious and parasitic diseases |
|
176.0-176.9 |
Kaposi’s sarcoma, skin |
|
180.0-180.9 |
Malignant neoplasm of endocervix |
|
200.20-200.28 |
Burkitt’s tumor or lymphoma unspecified site |
|
200.80-200.88 |
Other named variants of lymphosarcoma and reticulosarcoma unspecified site |
|
201.00-201.98 |
Hodgkin’s paragranuloma unspecified site |
|
263.0 |
Malnutrition of moderate degree |
|
263.1 |
Malnutrition of mild degree |
|
263.9 |
Unspecified protein-calorie malnutrition |
|
280.0-280.9 |
Iron deficiency anemia secondary to blood loss (chronic) |
|
285.9 |
Anemia unspecified |
|
287.30 |
Primary thrombocytopenia, unspecified |
|
287.31 |
Immune thrombocytopenic purpura |
|
287.32 |
Evans’ syndrome |
|
287.33 |
Congenital and hereditary thrombocytopenic purpura |
|
287.39 |
Other primary thrombocytopenia |
|
288.0 |
Agranulocytosis |
|
288.8 |
Other specified disease of white blood cells |
|
294.8 |
Other specified organic brain syndromes (chronic) |
|
310.1 |
Organic personality syndrome |
|
322.2 |
Chronic meningitis |
|
336.9 |
Unspecified disease of spinal cord |
|
348.3 |
Encephalopathy, unspecified |
|
354.0-354.9 |
Carpal tunnel syndrome |
|
356.8 |
Other specified idiopathic peripheral neuropathy |
|
363.20 |
Chorioretinitis unspecified |
|
425.4 |
Other primary cardiomyopathies |
|
473.0-473.9 |
Chronic maxillary sinusitis |
|
481-482.9 |
Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia] |
|
484.1 |
Pneumonia in cytomegalic inclusion disease |
|
486 |
Pneumonia organism unspecified |
|
512.8 |
Other spontaneous pneumothorax |
|
516.8 |
Other specified alveolar and parietoalveolar pneumonopathies |
|
528.2 |
Oral aphthae |
|
528.6 |
Leukoplakia of oral mucosa including tongue |
|
530.2 |
Ulcer of esophagus |
|
583.9 |
Nephritis and nephropathy not specified as acute or chronic with unspecified pathological lesion in kidney |
|
588.81 |
Secondary hyperparathyroidism (of renal origin) |
|
588.89 |
Other specified disorders resulting from impaired renal function |
|
647.60-647.64 |
Other viral diseases of mother complicating pregnancy, childbirth, or the puerperium unspecified as to episode of care |
|
682.0-682.9 |
Cellulitis and abscess of face |
|
690.10-690.18 |
Seborrheic dermatitis unspecified |
|
696.1 |
Other psoriasis and similar disorders |
|
698.3 |
Litchenification and lichen simplex chronicus |
|
704.8 |
Other specified diseases of hair and hair follicles |
|
706.0-706.9 |
Acne varioliformis |
|
780.6 |
Fever |
|
780.79 |
Other malaise and fatigue |
|
783.21 |
Loss of weight |
|
783.40 |
Unspecified lack of normal physiological development |
|
785.6 |
Enlargement of lymph nodes |
|
786.00 |
Respiratory abnormality unspecified |
|
786.05 |
Shortness of breath |
|
786.2 |
Cough |
|
786.3 |
Hemoptysis |
|
786.4 |
Abnormal sputum |
|
787.91 |
Diarrhea |
|
795.71 |
Nonspecific serologic evidence of human immunodeficiency virus (HIV) |
|
799.4 |
Cachexia |
|
V01.71 |
Varicella |
|
V01.79 |
Other viral diseases |
|
V71.5 |
Observation following alleged rape or seduction |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|